TNBC By Vineet Gupta
Session 5: TNBC
Chairpersons :
S H Advani, S Hukku
Speaker :
Vineet Gupta
Profiles of genome complexity identify HORMAD1 as a driver of homologous recombination deficiency and platinum therapy response in triple-negative breast cancer”
Author:A. Grigoriadis
Conference: IMPAKT
TITAN: Phase III study of doxorubicin/ cyclophosphamide (AC followed by ixabepilone(lxa) or paclitaxel (Pac) in early stage, triple-negative breast cancer (TNBC)
Author: D. A. Yardley
Conference: ASCO
Low-dose oral cycliphosphamide-methotrexate maintenance (CMM) for receptor negative early breast cancer (BC)
Author: M. Colleoni
Conference: ASCO